First synthesis of etidronate partial amides starting from PCl3.

Methods for the preparation of mixed tetra-amide esters 1 and 2, the partial amide ester 3, and tri- and P,P-diamides 4 and 5 from monophosphorus spieces 12, 8 and 9, respectively, were developed. Compounds 8 and 9 were obtained from phosphorus trichloride via MeOPCl2, which was treated with 2 eq. and 4 eq. of piperidine, followed by water or acetyl chloride, respectively. Tetrasubstituted amide bisphosphonates 1 and 2 were selectively dealkylated with lithium or silyl halide to achieve target compounds 3-5. Piperidine was found to be a good desilylation reagent. Quantum mechanical calculations illustrate why derivative 2 was produced in low yield. The usefulness of compounds 1, 3 and 4 as prodrugs of etidronate was determined in aqueous buffer and human serum.

[1]  T. Järvinen,et al.  BISPHOSPHONATE PRODRUGS. SYNTHESIS AND IDENTIFICATION OF (1-HYDROXYETHYLIDENE)-1,1-BISPHOSPHONIC ACID TETRAESTERS BY MASS SPECTROMETRY, NMR SPECTROSCOPY AND X-RAY CRYSTALLOGRAPHY , 2001 .

[2]  T. Järvinen,et al.  Bisphosphonate Prodrugs. Selective Synthesis of (1-Hydroxyethylidene)-1,1-bisphosphonate Partial Esters , 2001 .

[3]  M. K. Grachev,et al.  Amides of trivalent phosphorus acids as phosphorylating reagents for proton-donating nucleophiles. , 2000, Chemical reviews.

[4]  J. Vepsäläinen,et al.  Bisphosphonate prodrugs: synthesis and in vitro evaluation of alkyl and acyloxymethyl esters of etidronic acid as bioreversible prodrugs of etidronate. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[5]  H. Fleisch.  Bisphosphonates in Bone Disease: From the Laboratory to the Patient , 2000 .

[6]  H. Lönnberg,et al.  Protonation of phosphoramidites. The effect on nucleophilic displacement , 2000 .

[7]  J. Vepsäläinen,et al.  Bisphosphonate prodrugs: synthesis and in vitro evaluation of novel partial amides of clodronic acid , 1998 .

[8]  G. Rodan,et al.  Alendronate and osteoporosis , 1998 .

[9]  J. Vepsäläinen,et al.  Strategies for the selective synthesis of monosubstituted (dichloromethylene)bisphosphonate esters , 1997 .

[10]  J. Vepsäläinen,et al.  Simultaneous determination of clodronate and its partial ester derivatives by ion-pair reversed-phase high-performance liquid chromatography coupled with evaporative light-scattering detection. , 1997, Journal of chromatography. B, Biomedical sciences and applications.

[11]  B. Roos,et al.  Preparation and Identification of Tetraamide Esters of Methylene- and (Dichloromethylene)bisphosphonates. , 1997 .

[12]  S. Giannini,et al.  Continuous and Cyclical Clodronate Therapies and Bone Density in Postmenopausal Bone Loss , 1996, Obstetrics and gynecology.

[13]  J. Tomasi,et al.  Ab initio study of solvated molecules: A new implementation of the polarizable continuum model , 1996 .

[14]  S. Papapoulos.  The role of bisphosphonates in the prevention and treatment of osteoporosis. , 1993, The American journal of medicine.

[15]  E. Pohjala,et al.  Bisphosphonic compounds v. selective preparation of (dichloromethylene)bisphosphonate partial esters. , 1993 .

[16]  J. Vepsäläinen,et al.  BISPHOSPHONIC COMPOUNDS. IV.1 PREPARATION AND IDENTIFICATION OF MIXED TETRAALKYL METHYLENE- AND (DICHLOROMETHYLENE)-BISPHOSPHONATES BY NMR SPECTROSCOPIC, MASS SPECTROMETRIC AND X-RAY CRYSTALLOGRAPHIC STUDIES , 1992 .

[17]  R. Valkema,et al.  The use of bisphosphonates in the treatment of osteoporosis. , 1992, Bone.

[18]  H. Fleisch.  Bisphosphonates , 2012, Drugs.

[19]  V. Stella,et al.  Prodrugs , 1985, Drugs.

[20]  J. Tomasi,et al.  Electrostatic interaction of a solute with a continuum. A direct utilizaion of AB initio molecular potentials for the prevision of solvent effects , 1981 .

[21]  S. Yalkowsky,et al.  Rationale for design of biologically reversible drug derivatives: prodrugs. , 1975, Journal of pharmaceutical sciences.

[22]  R. Recker,et al.  Intestinal absorption of disodium ethane-1-hydroxy-1,1-diphosphonate (disodium etidronate) using a deconvolution technique. , 1973, Toxicology and applied pharmacology.

[23]  D. Nicholson,et al.  A General Method of Preparation of Tetramethyl Alkyl-1-hydroxy-1,1-diphosphonates , 1971 .